{
  "_template_version": "1.0",
  "_instructions": "Copy this directory to data/companies/{TICKER}/ and fill in the data",

  "name": "Company Name",
  "ticker": "TICK",
  "headquarters": "City, State",
  "website": "https://www.company.com",
  "ir_page": "https://ir.company.com",

  "description": "Brief company description (2-3 sentences)",

  "classification": {
    "development_stage": "mid_clinical",
    "modality": "small_molecule",
    "modality_subtype": "",
    "therapeutic_area": "oncology_precision",
    "therapeutic_subtype": ""
  },

  "financials": {
    "market_cap_mm": 0,
    "cash_mm": 0,
    "debt_mm": 0,
    "cash_runway": "Into 2027",
    "last_updated": "2026-01-01"
  },

  "fund_position": {
    "ownership_pct": 0,
    "cost_basis": 0,
    "priority": "high",
    "thesis_type": "binary_event"
  },

  "investment_thesis": [
    "Thesis point 1",
    "Thesis point 2",
    "Thesis point 3"
  ],

  "key_risks": [
    "Risk 1",
    "Risk 2",
    "Risk 3"
  ],

  "partnerships": [
    {
      "partner": "Partner Name",
      "asset": "Asset Name",
      "value": "$XXM upfront + milestones",
      "status": "Active",
      "notes": ""
    }
  ],

  "management": {
    "ceo": "CEO Name",
    "cmo": "CMO Name",
    "cfo": "CFO Name"
  },

  "targets": {
    "TARGET_NAME": {
      "name": "TARGET_NAME",
      "full_name": "Full Target Name",
      "type": "Kinase",
      "pathway": "Signaling pathway",
      "validation": {
        "genetic": "Genetic validation evidence",
        "clinical": "Clinical validation evidence"
      },
      "why_undrugged": "Why this target was previously difficult",
      "companies_developing": [
        {"company": "Company Name", "asset": "Asset Name", "stage": "Phase X", "mechanism": "Mechanism"}
      ]
    }
  }
}
